LIGHT INDUCED VISUAL-RESPONSE

LIGHT INDUCED VISUAL-RESPONSE
Colin Kerr
Colin Kerr
Published: Thursday, November 1, 2018
Diopsys introduced the concept of Light Induced Visual-Response (LIV) to delegates at the 36th Congress of the ESCRS. Earlier this year, Diopsys reframed the kind of testing performed on its medical devices. A company spokesman said the decision was an acknowledgement that visual electrophysiology testing has a perception within the eye-care community that does not reflect the modern protocols and platforms Diopsys provides. By using patented skin sensors Diopsys LIV testing is patient friendly and because of the small physical footprint of their devices, testing is readily accessible to clinicians. “When we heard from physicians that traditional electrophysiology testing might be too complicated and might not be relevant to everyday practice, we sensed a need to clarify what Diopsys platforms add to routine eye care. In talking about LIV, we are calling it exactly what it is: a measure of electrical response within the cells along the visual pathway to a light-based stimulus,” said Bill Shields, Vice President, International Sales, Diopsys. http://diopsys.com
Tags: electrophysiology, Light Induced Visual-Response
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...